No Detail Found!

Management of decompensated Cirrhosis due to HbeAg-negative chronic HBV infection with lamivudine monotherapy.

Author(s)
Suhail Ahmed Almani Department of Medicine, Liaquat Univeristy of Medical and Health Sciences, Jamshoro, Sindh, Pakistan
Iqbal Memon Department of Medicine, Liaquat Univeristy of Medical and Health Sciences, Jamshoro, Sindh, Pakistan
Abdul Sattar Memon Department of Surgery, Liaquat Univeristy of Medical and Health Sciences, Jamshoro, Sindh, Pakistan
Jawed Memon Department of Medicine, Isra University, Hala Road, Hyderabad, Sindh, Pakistan
Allah Bachayo Memon Faculty of Medicine and Allied Sciences, Liaquat Univeristy of Medical and Health Sciences, Jamshoro, Sindh, Pakistan
Abstract
To evaluate the efficacy of long-term lamivudine monotherapy in patients with decompensated cirrhosis due to HbeAg-negative/HBV- DNA positive. DESIGN: Case - control study. SETTING: Departments of Medicine and Surgery, Liaquat University Hospital, Jamshoro, and Isra University Hospital Hyderabad, from March 2000 to June 2003. PATIENTS AND METHODS: We analyzed the clinical course and outcome of lamivudine treatment in 30 consecutive cirrhotics and compared with 30 HBV untreated HbeAg-negative controls. RESULTS: Significant clinical improvement, defined as a reduction of at least two points in Child-Pugh score was observed in 23 of the 30 treated patients (76.6%) versus none of the 30 patients in the control group (p
Publication Details
Page(s) 69-73
DOI DOI not available
Published Journal: Journal of Liaquat University of Medical and Health Sciences, Volume: 3, Issue: 2, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

46

Views